FDA NDC Directory · JSON-LD · Markdown

Glatiramer Acetate

NDC 0378-6961 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameGlatiramer
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA206936
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsGLATIRAMER ACETATE (40 mg/mL)
Marketing started20171004
Package count1

External sources

Source: openFDA. Public-domain (CC0).